FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

703348000: Tafamidis (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3008259011 Tafamidis en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3008267015 Tafamidis (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
933531000195112 tafamidis it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
843471000172113 tafamidis fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tafamidis Is a Central nervous system agent (substance) true Inferred relationship Some
Tafamidis Is a Dichlorobenzene true Inferred relationship Some
Tafamidis Is a Carboxylic acid true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Tafamidis meglumine (substance) Is a False Tafamidis Inferred relationship Some
Product containing tafamidis (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tafamidis Inferred relationship Some 1
Tafamidis meglumine (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Tafamidis Inferred relationship Some
Tafamidis-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tafamidis Inferred relationship Some 1
Tafamidis only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tafamidis Inferred relationship Some 1
Product containing only tafamidis in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tafamidis Inferred relationship Some 1
Product containing precisely tafamidis 61 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tafamidis Inferred relationship Some 1
Product containing precisely tafamidis 61 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tafamidis Inferred relationship Some 1

This concept is not in any reference sets

Back to Start